A Phase 1, Open-label, Single-center, 2-period, Single Sequence Drug-drug Interaction Study to Evaluate the Effects of Multiple-dose Telotristat Etiprate on the Pharmacokinetics of Single-dose Fexofenadine, a Sensitive P Glycoprotein Substrate, in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2014
Price : $35 *
At a glance
- Drugs Telotristat etiprate (Primary) ; Fexofenadine
- Indications Malignant carcinoid syndrome
- Focus Pharmacokinetics
- Sponsors Lexicon Pharmaceuticals
- 05 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 11 Jun 2014 New trial record